Penicillin pharmacodynamics in four experimental pneumococcal infection models

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 4, 2001, Pages 1078-1085

  Erlendsdottir, H ^a   Knudsen, J D ^a   Odenholt, I ^a   Cars, O ^a   Espersen, F ^a   Frimodt Moller N ^a   Fuursted, K ^a   Kristinsson, K G ^a   Gudmundsson, S ^a  

^a NONE   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BACTERIAL COUNT; BACTERIAL PERITONITIS; BACTERIAL PNEUMONIA; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG PROTEIN BINDING; FEMALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RABBIT; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; DIFFUSION CHAMBERS, CULTURE; DRUG ADMINISTRATION SCHEDULE; HALF-LIFE; LUNG; MICE; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PENICILLINS; PERITONEUM; PERITONITIS; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; RABBITS; SERUM BACTERICIDAL TEST; THIGH;

EID: 0035083934     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.4.1078-1085.2001     Document Type: Article

References (32)

1. Antimicrobial resistance in Streptococcus pneumoniae: An overview
2. Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains
3. Static and dynamic properties of tissue cage fluids in rabbits
4. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae
5. Tissue distribution of ampicillin: Assay in muscle tissue and subcutaneous tissue cage fluid from normal and nephrectomized rabbits
6. Penetration of ampicillin and dicloxacillin into tissue cage fluid in rabbits: Relation to serum and tissue protein binding
7. Protein binding and antimicrobial effects: Methods for determination of protein binding
8. Relevance of the Alexander Project: Pharmacodynamic considerations
9. Pneumonia caused by penicillin non-susceptible and penicillin susceptible pneumococci in adults: A case-control study
10. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease
11. Experimental pneumococcus infection in mice: Comparative in vitro activity and pharmacokinetic parameters with in vivo effect for 14 Cephalosporins
12. The mouse peritonitis/sepsis model
13. Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats
14. Impact of the antibiotic dosages schedule on efficacy in experimental soft tissue infections
15. Murine thigh infection model
16. A resistant pneumococcus
17. Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types
18. Management of infections due to antibiotic-resistant Streptococcus pneumoniae
19. Measurement of antibiotics in human body fluids: Techniques and significance
20. Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin
21. Pharmacodynamics of penicillin are unaffected by bacterial growth phases of Streptococcus pneumoniae in the mouse peritonitis model
22. Streptococcus pneumoniae
23. An in vivo model for evaluation of the postantibiotic effect
24. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain
25. Impact of the antibiotic dosage schedule on efficacy in experimental lung infections
26. Antibiotic assays in muscle: Are conventional tissue levels misleading as indicator of the antibacterial activity?
27. Evidence for introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980's
28. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model
29. Pneumococcus at the gates
30. The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth
31. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model